Conclusion
The results of the psychometric analyses and exit interviews from the cross-sectional study along with the longitudinal psychometric analyses from ENSEMBLE2 support use of the SIC in both treatment and vaccine clinical trials, pending future work to evaluate the responsiveness of the SIC.